Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current earnings are ยฃ12.85 Billion. a decrease over its 2023 earnings that were of ยฃ0.10 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -ยฃ0.45 Billion | -545.86% |
2023 | ยฃ0.10 B | -105.3% |
2022 | -ยฃ1.89 Billion | -269.8% |
2021 | ยฃ1.11 B | 14.32% |
2020 | ยฃ0.97 B | 33.2% |
2019 | ยฃ0.73 B | -41.53% |
2018 | ยฃ1.24 B | 36.32% |
2017 | ยฃ0.91 B | -75.43% |
2016 | ยฃ3.72 B | 1057.48% |
2015 | ยฃ0.32 B | -79.17% |
2014 | ยฃ1.54 B | -18.81% |
2013 | ยฃ1.90 B | -12.39% |
2012 | ยฃ2.17 B | 2.85% |
2011 | ยฃ2.11 B | 48.62% |
2010 | ยฃ1.42 B | -30.87% |
2009 | ยฃ2.05 B | 11.05% |
2008 | ยฃ1.85 B | 16.46% |
2007 | ยฃ1.59 B | 21.08% |
2006 | ยฃ1.31 B | 20.91% |
2005 | ยฃ1.08 B | 233.49% |
2004 | ยฃ0.32 B | -62.22% |
2003 | ยฃ0.86 B | -18.08% |
2002 | ยฃ1.05 B | 45.12% |
2001 | ยฃ0.72 B | 1.9% |
2000 | ยฃ0.71 B | -9.99% |
1999 | ยฃ0.79 B | 99.43% |
1998 | ยฃ0.39 B | 0.76% |
1997 | ยฃ0.39 B | -34.05% |
1996 | ยฃ0.59 B | 51.34% |
1995 | ยฃ0.39 B | -34.58% |
1994 | ยฃ0.60 B | -342.73% |
1993 | -ยฃ0.25 Billion | -142.36% |
1992 | ยฃ0.58 B | -3.23% |
1991 | ยฃ0.60 B | 666.67% |
1990 | ยฃ79.03 M | -83.52% |
1989 | ยฃ0.47 B | -14.5% |
1988 | ยฃ0.56 B | 7.66% |
1987 | ยฃ0.52 B | 26.74% |
1986 | ยฃ0.41 B | 115.3% |
1985 | ยฃ0.19 B | 10.84% |
1984 | ยฃ0.17 B |